Insulin as Monotherapy and in Combination with Other Glucose-Lowering Drugs Is Related to Increased Risk of Diagnosis of Pneumonia: A Longitudinal Assessment over Two Years.

Michael LeutnerMichaela KaletaLuise BellachAlexander KautzkyStefan ThurnerPeter KlimekAlexandra Kautzky-Willer

Published in: Journal of personalized medicine (2021)

Stable monotherapy with insulin, but also in combination with other antidiabetic drugs, is related to an increased risk of being diagnosed with pneumonia during hospital stays in patients with type 2 diabetes mellitus compared to untreated controls.

Keyphrases

type diabetes
combination therapy
glycemic control
open label
blood glucose
healthcare
community acquired pneumonia
respiratory failure
emergency department
acute care
blood pressure
intensive care unit
insulin resistance
double blind
clinical evaluation